In a report released today, William Bonello from Craig-Hallum reiterated a Buy rating on Guardant Health (GH – Research Report), with a price ...

BTIG analyst Mark Massaro reiterated a Buy rating on Guardant Health (GH – Research Report) yesterday and set a price target of $60.00. The ...

Guardant Health has an expanding pipeline that could significantly boost its future market potential. Check out my ...

Guardant Health (NASDAQ:GH) traded higher in the morning hours on Tuesday after the company announced that the U.S. Centers ...

Diagnostics company Guardant Health (NASDAQ:GH) in Q4 CY2024, with sales up 30.2% year on year to $201.8 million. Its GAAP loss of $0.90 per share was 12.4% below analysts’ consensus estimates. Is now ...

Jones Financial Companies Lllp boosted its holdings in Guardant Health, Inc. (NASDAQ:GH – Free Report) by 43.5% in the 4th quarter, HoldingsChannel reports. The firm owned 2,696 shares of the ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced a collaboration with Dak Prescott’s Faith Fight Finish Found ...

Feb 21 - Medical diagnostics company Guardant Health (GH.O), opens new tab has sued rival Natera (NTRA.O), opens new tab in California federal court for allegedly stealing trade secrets related to ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the Centers for Medicare & Medicaid ...

March is Colorectal Cancer Awareness Month, and it’s important to know the risks that come along with it. Vice President of ...

Arizona State Retirement System grew its holdings in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) by 1.1% during ...

Diagnostics company Guardant Health (NASDAQ:GH) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 30.2% year on year to $201.8 million. Its GAAP loss of $0.90 per share was 12. ...